Arcellx Inc.(NASDAQ:ACLX) 
Arcellx, Inc., a clinical-stage biotechnology company, is engaged in the development of various immunotherapies for patients with cancer and other incurable diseases. The company is headquartered in Gaithersburg, Maryland.
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 60.03
H 63.14
L 58.00
C 58.59
V 1,136,038
10EMA 58.59
20EMA 58.59
60EMA 58.59
120EMA 58.59
250EMA 58.59